The drug company people worry about losing faces generic rivals as early as April 2028. The newer products already make up most of the revenue.
Oct 14, 2026
•
8 min read
Restaurant fries come from somewhere, and one of the biggest suppliers just beat, raised guidance, and still pays you over three percent to hold it.
Oct 12, 2026
Everyone is sure AI will gut this industry. Meanwhile, the company is cutting $1.5 billion in costs and paying you over 4% to be patient.
Oct 9, 2026
9 min read
Four billion dollars changed hands last month and the share price barely blinked. The acreage behind that deal is about to start showing up in the numbers.
Oct 7, 2026
Some children with heart defects need repeat open-heart surgery as they grow. One company just won approval for a valve designed to expand as they grow.
Oct 5, 2026
Most companies control their own profits. This one leaves it to a government score it can push on but cannot decide.
Oct 2, 2026
You have four or five of their products in a cupboard right now. The stock trades at roughly 60% of the business's value. Here is the number that matters tomorrow.
Sep 30, 2026
High car prices and high loan rates have crushed demand. The company's leadership has responded by buying shares, not selling them.
Sep 28, 2026
Most endorsement deals are a cheque and a photo shoot. This one handed the athlete equity, so he now needs the share price to work too.
Sep 25, 2026
Three separate board members bought shares within five days of each other. Then an activist investor showed up demanding the CEO be replaced.
Sep 23, 2026
7 min read
A cancer trial worked in most patients and fell short in one smaller group. That nuance got flattened into a single ugly day of selling.
Sep 21, 2026
This travel software stock grew revenue 38% and cut its loss nearly in half. Now management expects another 30% growth quarter.
Sep 18, 2026
When a takeout gets announced at double the price, the gap usually vanishes within days. This one has not entirely. See why that remaining sliver is worth a look.
Sep 16, 2026
Revenue has taken a hit from a major business transition, but recurring cash flow has been moving in the opposite direction. The next few quarters could expose the gap.
Sep 14, 2026
Two years of volume pressure have beaten this grocery stock down. You do not need a turnaround for the math to start looking very different.
Sep 11, 2026
Two unloved years in this corner of the market built the gap. One filing could shut most of it in a single session. Everything hinges on four words from management, and almost nobody is positioned for them.
Sep 9, 2026
You buy this company’s products without noticing. That invisibility is exactly why the stock got left in the discount bin.
Sep 7, 2026
You have almost certainly used this website. Its stock trades at roughly half what the business is estimated to be worth.
Sep 4, 2026
One overlooked insurance stock keeps growing, improving profits, and getting cheaper while the market looks elsewhere.
Sep 2, 2026
Executives at this discount grocery chain bought roughly $8 million of company stock over the past year. Shares still trade well below fair value.
Aug 31, 2026
The PC cycle is hardly booming. That may be exactly why the market is overlooking what the latest cash numbers are saying.
Aug 28, 2026
The next few weeks bring clinical data, a regulatory date, and a chance to test whether estimates are too low. Find out which catalyst could shift the setup.
Aug 26, 2026
Back-to-school inventory is clean, the balance sheet carries no net debt, and the little brother brand quietly became the bigger business.
Aug 24, 2026
Homebuilders need people to move house. This one just needs roofs to age and attics to stay cold. Two very different risk profiles, one much cheaper.
Aug 21, 2026
Roofing posted its best revenue quarter in company history, and the stock dropped 8.4%. Insiders responded by buying 12 times, with no sells.
Aug 19, 2026
